HCA Healthcare, Inc. $HCA Shares Sold by Hudson Edge Investment Partners Inc.

Key Points

• Hudson Edge Investment Partners Inc. has reduced its stake in HCA Healthcare by 19.5%, now holding 17,418 shares, valued at approximately $6.67 million.
• Institutional investors own around 62.73% of HCA Healthcare's stock, with significant increases in holdings from firms like Nuveen LLC and Pacer Advisors Inc.
• HCA Healthcare recently announced a quarterly dividend of $0.72, reflecting an annualized yield of 0.7% and a payout ratio of 12.11%.

Hudson Edge Investment Partners Inc. cut its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 19.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 17,418 shares of the company's stock after selling 4,218 shares during the quarter. HCA Healthcare comprises 1.1% of Hudson Edge Investment Partners Inc.'s holdings, making the stock its 22nd biggest position. Hudson Edge Investment Partners Inc.'s holdings in HCA Healthcare were worth $6,673,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in HCA. Nuveen LLC acquired a new stake in HCA Healthcare in the 1st quarter valued at approximately $569,217,000. Pacer Advisors Inc. increased its stake in HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock valued at $466,815,000 after buying an additional 1,329,618 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after acquiring an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. raised its holdings in HCA Healthcare by 49.1% during the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after purchasing an additional 587,036 shares in the last quarter. Finally, Abdiel Capital Advisors LP bought a new position in HCA Healthcare during the 1st quarter valued at $164,835,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.30% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on HCA shares. Morgan Stanley decreased their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research note on Monday, July 28th. Bank of America boosted their target price on shares of HCA Healthcare from $375.00 to $410.00 and gave the stock a "neutral" rating in a report on Wednesday, September 10th. Royal Bank Of Canada decreased their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research report on Monday, July 28th. Wells Fargo & Company decreased their target price on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a report on Thursday, August 14th. Finally, JPMorgan Chase & Co. increased their price target on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $407.75.

HCA Healthcare Price Performance

NYSE:HCA opened at $426.81 on Friday. The stock's 50-day moving average is $395.62 and its two-hundred day moving average is $371.70. The stock has a market cap of $99.87 billion, a PE ratio of 17.94, a price-to-earnings-growth ratio of 1.34 and a beta of 1.40. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $429.43.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm's revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare's dividend payout ratio is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.